HIPRADOG DHLP VACCINE

Indications

• Pain management
• Inflammation
• Infections
• Chronic diseases
• Allergic reactions

Dosage

Children: Dosage for paediatric canines (puppies) also varies widely depending on the specific medication, age, and weight of the puppy. Veterinary guidance is crucial for determining appropriate doses.

Adults: Dosage for adult canines varies based on the specific medication and condition being treated. It is essential to consult veterinary guidelines or a veterinarian for appropriate dosing.

Mechanism of action

The mechanism of action of canine medications varies widely depending on the specific drug class. For example, non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing the production of prostaglandins that mediate inflammation and pain. Antibiotics may work by inhibiting bacterial cell wall synthesis or protein synthesis, while corticosteroids reduce inflammation by inhibiting immune response.

Pharmacodynamics

Pharmacodynamics in canines involves understanding how drugs affect the body, including their therapeutic effects and potential side effects. For example, NSAIDs provide analgesic and anti-inflammatory effects, while antibiotics target specific pathogens to eliminate infections. The response to drugs can vary based on factors such as breed, age, and overall health status.

Pharmacokinetics

Pharmacokinetics in canine patients encompasses the absorption, distribution, metabolism, and excretion of drugs. Canine physiology can influence these processes; for example, drugs may be absorbed more quickly in dogs due to differences in gastrointestinal pH and transit time. Metabolism often occurs in the liver, with variations based on breed and age affecting drug clearance. Excretion primarily takes place through the kidneys.

Pregnancy

Safety during pregnancy has not been established. Consult a veterinarian for guidance.

Breast-feeding

Safety during lactation has not been established. Consult a veterinarian for guidance.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Prevention of canine distemper through vaccination
• Supportive treatment for infected dogs

Dosage

Children: No specific dosage available, refer to guidelines for vaccination schedules.

Adults: No specific dosage available, refer to guidelines for vaccination schedules.

Mechanism of action

Canine distemper virus primarily infects and replicates in lymphoid tissue, leading to immune suppression, and subsequently affects epithelial tissues in the respiratory, gastrointestinal, and nervous systems. The virus enters host cells via the signaling lymphocytic activation molecule (SLAM) receptor, which is expressed on immune cells, facilitating its spread throughout the body.

Pharmacodynamics

The immune response to CDV involves both humoral and cellular immunity. Vaccination induces an immune response that generates neutralizing antibodies, which prevent viral entry into host cells. Infected animals may develop severe immunosuppression, making them susceptible to secondary infections. The clinical manifestations depend on the severity of the infection and the host's immune response.

Pharmacokinetics

The pharmacokinetics of canine distemper virus are not typically described in terms of absorption, distribution, metabolism, and excretion like conventional drugs. Instead, the focus is on viral replication and the host immune response. The incubation period for distemper can vary but generally ranges from 1 to 2 weeks. The duration of the immune response post-vaccination can last for several years, depending on the type of vaccine used.

Pregnancy

No specific data available on the effects of distemper treatment in pregnant individuals, consult relevant guidelines.

Breast-feeding

No specific data available on the effects of distemper treatment during breastfeeding, consult relevant guidelines.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Acute viral hepatitis
• Chronic hepatitis B
• Chronic hepatitis C
• Autoimmune hepatitis
• Alcoholic hepatitis
• Non-alcoholic fatty liver disease

Dosage

Children: Paediatric dosing also varies significantly based on the specific condition and medication. As with adult dosing, it is important to refer to the BNF for Children for specific recommendations.

Adults: Dosing for adult patients varies widely depending on the specific antiviral agent used and the type of hepatitis. It is essential to refer to specific guidelines or the BNF for precise dosing.

Mechanism of action

In viral hepatitis, the viruses typically enter liver cells and replicate, leading to cellular injury and inflammation. The immune response to the infection contributes to liver damage. Antiviral therapies aim to inhibit viral replication, either by directly targeting viral enzymes or by modulating the host immune response.

Pharmacodynamics

The pharmacodynamics of antiviral agents used in hepatitis treatment involve the inhibition of viral replication, reduction of viral load, and improvement of liver function. This can lead to a decrease in serum liver enzymes (ALT and AST) and an improvement in clinical symptoms. In chronic hepatitis B and C, sustained virologic response is the goal, indicating effective viral suppression.

Pharmacokinetics

The pharmacokinetics of antiviral medications used for hepatitis can vary significantly depending on the specific drug. Generally, these agents are absorbed from the gastrointestinal tract, metabolized in the liver, and excreted through urine or feces. The half-lives of these drugs can vary, influencing dosing schedules.

Pregnancy

Consult medical guidelines as hepatitis can pose risks during pregnancy; specific management depends on the type of hepatitis.

Breast-feeding

Consult healthcare providers, as the safety of certain hepatitis medications during breastfeeding varies.

Storage

Store in a cool, dry place away from direct sunlight; specific storage conditions may vary based on the medication used.

Indications

• Hepatitis A
• Hepatitis B
• Influenza
• Polio
• Rabies
• Typhoid fever

Dosage

Children: Refer to specific product guidelines for paediatric dosing, as it varies by vaccine type and indication.

Adults: Refer to specific product guidelines for adult dosing, as it varies by vaccine type and indication.

Mechanism of action

Inactivated vaccines work by introducing a form of the pathogen that cannot cause disease into the body. This stimulates the immune system to produce antibodies and memory cells specific to the pathogen, allowing for a robust immune response upon future exposure. The immune system recognizes the inactivated pathogen as foreign, leading to the activation of T-cells and B-cells, which are crucial for long-term immunity.

Pharmacodynamics

The pharmacodynamics of inactivated vaccines involve the generation of an adaptive immune response. After vaccination, the body produces specific antibodies against the inactivated pathogen. The response typically includes both humoral immunity, characterized by antibody production, and cellular immunity, involving T-cell activation. The duration of immunity can vary, and booster doses may be required to maintain adequate protection.

Pharmacokinetics

Inactivated vaccines do not have a pharmacokinetic profile like traditional drugs since they do not enter systemic circulation in the same manner. Following administration, the vaccine components are taken up by antigen-presenting cells, which process and present the antigens to T-cells. The immune response is initiated locally at the site of injection and can be influenced by factors such as the route of administration and the presence of adjuvants that enhance the immune response.

Adverse effects

• Injection site reactions (pain, swelling, redness)
• Fever
• Fatigue
• Headache
• Myalgia
• Chills

Precautions

• Assess for allergies to vaccine components
• Monitor for allergic reactions post-administration
• Consider underlying health conditions that may affect immune response

Pregnancy

Inactivated vaccines are generally considered safe during pregnancy, but individual risk-benefit assessment is recommended.

Breast-feeding

Inactivated vaccines can be administered during breastfeeding without concern for adverse effects in the infant.

Storage

Store in a refrigerator at 2°C to 8°C. Do not freeze.

Formulations

• Inactivated viral vaccines
• Inactivated bacterial vaccines

Indications

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections
• Sepsis
• Pneumonia
• Urinary tract infections
• Skin and soft tissue infections
• Gastrointestinal infections

Dosage

Children: Refer to BNF for Children and

Adults: Refer to appropriate antimicrobial guidelines and specific drug BNF entries for dosing.

Mechanism of action

Antimicrobial agents function through various mechanisms depending on their class. Bactericidal agents kill bacteria directly, while bacteriostatic agents inhibit bacterial growth. Common mechanisms include inhibition of cell wall synthesis (e.g., penicillins), disruption of nucleic acid synthesis (e.g., fluoroquinolones), interference with protein synthesis (e.g., aminoglycosides), and alteration of cell membrane permeability (e.g., polymyxins). Antiviral agents may inhibit viral entry, replication, or assembly. Antifungal agents disrupt fungal cell membranes or inhibit synthesis of essential components like ergosterol.

Pharmacodynamics

Antimicrobial agents exhibit concentration-dependent or time-dependent killing effects. Their efficacy can be influenced by the site of infection, the immune response of the host, and the presence of resistant strains. The minimum inhibitory concentration (MIC) is a critical parameter that helps determine the appropriate dosing regimen for effective treatment. Adverse effects can include toxicity to host cells, disruption of normal flora, and allergic reactions.

Pharmacokinetics

Pharmacokinetics of antimicrobial agents encompass absorption, distribution, metabolism, and excretion (ADME). Most antibiotics are absorbed in the gastrointestinal tract, though some may require intravenous administration for systemic infections. Distribution varies, with some agents achieving higher concentrations in certain tissues or fluids (e.g., cerebrospinal fluid, lung tissue). Metabolism often occurs in the liver, with various pathways leading to active or inactive metabolites. Renal excretion is common, necessitating dose adjustments in patients with renal impairment.

Adverse effects

• Nausea
• Diarrhea
• Allergic reactions
• Rash
• Dizziness
• Headache

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• Can interact with certain antiretrovirals, affecting their efficacy
• Potential interaction with cytochrome P450 substrates

Precautions

• Use with caution in patients with renal impairment
• Monitor liver function in patients with liver disease
• Assess for potential allergic reactions in patients with a history of drug allergies

Pregnancy

Considered safe in pregnancy for certain infections, but risk-benefit analysis is required.

Breast-feeding

Generally safe, but consult a healthcare professional for specific medications.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Tablets
• Capsules
• Suspensions
• Injectables

Indications

• Acute pain management
• Nausea and vomiting control
• Antibiotic therapy
• Vaccinations
• Insulin administration for diabetes
• Chemotherapy for cancer treatment
• Emergency medications for cardiac arrest or anaphylaxis

Dosage

Children: Refer to the BNF for Children for appropriate dosing.

Adults: Refer to specific drug guidelines in the BNF for appropriate dosing.

Mechanism of action

The mechanism of action for injectable drugs varies widely depending on the specific drug. Generally, injectable medications can act through various pathways such as receptor agonism or antagonism, enzyme inhibition, or modulation of cellular processes. For instance, antibiotics may inhibit bacterial cell wall synthesis, while analgesics may act on pain receptors in the nervous system.

Pharmacodynamics

Pharmacodynamics refers to the effects of injectable drugs on the body and their mechanisms of action at the target sites. This includes the relationship between drug concentration and effect, the duration of action, therapeutic indices, and potential side effects. Injectable drugs may exhibit dose-dependent effects, with higher doses typically leading to more pronounced therapeutic or adverse effects.

Pharmacokinetics

Pharmacokinetics describes the absorption, distribution, metabolism, and excretion of injectable drugs. Following injection, drugs rapidly enter the bloodstream, allowing for immediate therapeutic action. Factors that influence pharmacokinetics include the injection site, formulation, and patient-specific variables such as age, weight, and organ function. The drug's half-life will determine the frequency of dosing and the potential for accumulation in the body.

Pregnancy

The use of injectable drugs during pregnancy depends on the specific drug. It is essential to assess the risk versus benefit for both mother and fetus. Some injectable drugs may be contraindicated during pregnancy.

Breast-feeding

Many injectable drugs can pass into breast milk. It is crucial to consider the safety of the drug for the breastfeeding infant and the necessity of the drug for the mother.

Storage

Injectable drugs should be stored according to manufacturer specifications, typically in a cool, dry place, away from light. Some may require refrigeration.

Indications

• Croup
• Laryngotracheobronchitis
• Viral upper respiratory infections

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on age and weight.

Adults: Refer to specific clinical guidelines for dosing; corticosteroids may be indicated for moderate to severe cases.

Mechanism of action

Corticosteroids reduce inflammation and edema in the airway, thus alleviating symptoms of laryngotracheitis. They act by inhibiting the release of inflammatory mediators and suppressing the immune response, leading to decreased airway swelling and improved airflow.

Pharmacodynamics

Corticosteroids exert their effects by binding to glucocorticoid receptors, resulting in altered gene expression that reduces the production of pro-inflammatory cytokines. This leads to decreased vascular permeability and reduced infiltration of inflammatory cells. The onset of action varies depending on the specific steroid used, with some providing rapid relief of symptoms.

Pharmacokinetics

The pharmacokinetics of corticosteroids can vary widely among different agents; however, they are generally well-absorbed when administered orally or via inhalation. Metabolism occurs primarily in the liver, and elimination is typically via urine. The half-life can vary significantly, influencing dosing frequency.

Indications

• Leptospirosis
• Severe leptospirosis with renal failure
• Leptospirosis with jaundice
• Leptospirosis with pulmonary hemorrhage

Dosage

Children: Refer to specific pediatric dosing guidelines for the treatment of leptospirosis based on the chosen antibiotic

Adults: Refer to specific antibiotic guidelines for treatment of leptospirosis, typically involving doxycycline or penicillin, depending on the severity and clinical presentation.

Mechanism of action

Leptospira bacteria penetrate the mucous membranes or broken skin, entering the bloodstream and disseminating throughout the body. They evade the immune system and can replicate within host tissues, leading to an inflammatory response. The bacteria primarily target the liver and kidneys, causing cellular damage and dysfunction. Antibiotics such as doxycycline or penicillin are effective in inhibiting bacterial growth and promoting clearance from the body.

Pharmacodynamics

Antibiotics used to treat leptospirosis work by inhibiting bacterial cell wall synthesis, protein synthesis, or nucleic acid synthesis, depending on the class of antibiotic. This results in bacterial cell death or inhibition of growth. The immune response is also activated, assisting in the clearance of the infection. The severity of symptoms and the extent of organ involvement may influence the pharmacodynamic response to treatment.

Pharmacokinetics

The pharmacokinetics of antibiotics used for leptospirosis varies by the specific medication. For instance, doxycycline is well-absorbed after oral administration, with a bioavailability of approximately 90%. It is distributed widely in body tissues and fluids, and it is primarily excreted in urine. Penicillin, on the other hand, is less well-absorbed orally but is effective when given parenterally, with rapid distribution to body tissues. Both drugs undergo renal elimination, making dose adjustments necessary in patients with renal impairment.

Adverse effects

• Fever
• Headache
• Muscle aches
• Red eyes
• Jaundice
• Abdominal pain
• Diarrhea
• Rash
• Cough
• Meningitis
• Kidney damage

Precautions

• Use caution in individuals with liver disease
• Monitor renal function in patients with renal impairment
• Consider the potential for severe illness in pregnant women

Pregnancy

Limited data available; consult healthcare professionals for risks and benefits.

Breast-feeding

Limited data available; consult healthcare professionals for risks and benefits.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Measles
• Mumps
• Rubella
• Varicella (chickenpox)
• Yellow fever
• Rotavirus
• Intranasal influenza

Dosage

Children: Refer to the BNF for Children for specific dosing information based on age and vaccine type.

Adults: Refer to specific product guidelines for dosing information, as it can vary by vaccine type and brand.

Mechanism of action

Live vaccines work by introducing a weakened or attenuated form of a pathogen into the body. This stimulates the immune system to recognize and respond to the pathogen, leading to the production of antibodies and memory cells that provide long-term protection against future infections by the same pathogen.

Pharmacodynamics

The pharmacodynamics of live vaccines involve the activation of both humoral and cellular immunity. Following vaccination, the immune system generates a robust response, including the production of specific antibodies and the activation of T cells that can recognize and eliminate infected cells. This dual action helps establish long-term immunity.

Pharmacokinetics

The pharmacokinetics of live vaccines vary depending on the specific vaccine. Generally, the vaccine is administered via injection, allowing the live attenuated organisms to enter the bloodstream. The immune response typically begins within days and can last for years, depending on the vaccine. Live vaccines are usually stored under refrigeration to maintain their viability, and they should be administered within their expiration dates.

Interactions

• livevaccines + abrocitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + baricitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + filgotinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + dexrazoxane: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + iron chelators: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + ponesimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + upadacitinib: Severe (increases risk of generalised infection (possibly life-threatening))
• livevaccines + diroximelfumarate: Moderate (increases risk of generalised infection (possibly life-threatening))

Indications

• Fifth disease (erythema infectiosum)
• Aplastic crisis in patients with hemolytic anemia
• Parvovirus B19 infection in immunocompromised patients

Dosage

Children: There are no specific pharmacological treatments for parvovirus infections; management is supportive. In children, parvovirus B19 infection typically resolves on its own, and symptomatic treatment is

Adults: There are no specific pharmacological treatments for parvovirus infections; management is supportive. Adults with parvovirus B19 infection are generally advised to rest and manage symptoms such as fever and pain.

Mechanism of action

Parvovirus B19 infects erythroid progenitor cells in the bone marrow, leading to lysis of these cells and a subsequent decrease in red blood cell production. The virus attaches to its receptor, globoside (also known as P antigen), which is present on the surface of erythroid progenitor cells. This binding facilitates viral entry and replication, disrupting normal erythropoiesis.

Pharmacodynamics

Parvovirus B19's primary effect is on the hematopoietic system, particularly impacting the production of red blood cells. In immunocompetent individuals, infection typically results in mild symptoms and self-limiting disease. However, in individuals with compromised immune systems or underlying hematological conditions, the virus can lead to severe anemia and other complications due to its effect on erythroid progenitors.

Pharmacokinetics

Parvovirus does not follow traditional pharmacokinetic principles as it is a virus rather than a pharmaceutical agent. Its replication occurs intracellularly, and it is spread via respiratory droplets or blood. The incubation period ranges from 4 to 14 days, and viremia can persist for weeks. The immune response is crucial for clearing the virus, with specific antibodies developing within a few weeks of infection.

Adverse effects

• Fever
• Malaise
• Rash
• Joint pain
• Anemia
• Lethargy

Precautions

• Immunocompromised patients may experience more severe symptoms.
• Pregnant women should be cautious due to potential risks to the fetus.

Pregnancy

Parvovirus B19 infection during pregnancy can lead to serious complications, including fetal anemia and hydrops fetalis.

Breast-feeding

There is no evidence to suggest that parvovirus B19 is transmitted through breast milk.

Storage

Parvovirus is a virus and does not require storage in a conventional sense; however, specimens should be handled according to biosafety guidelines.

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, hepatitis B, influenza, and human papillomavirus (HPV)
• Travel vaccinations for diseases endemic to certain regions
• Vaccination for at-risk populations, such as those with compromised immune systems or specific occupational exposures

Dosage

Children: Dosage varies by vaccine type and age; refer to the BNF for Children for specific dosing information.

Adults: Dosage varies by vaccine type and indication; refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by mimicking an infection. They introduce a harmless component of a pathogen (antigen) to the immune system, prompting the body to produce an immune response. This includes the generation of antibodies and memory cells that provide long-term immunity. Upon subsequent exposure to the actual pathogen, the immune system is primed to respond more rapidly and effectively.

Pharmacodynamics

The pharmacodynamics of vaccines involves the activation of both humoral and cellular immunity. Vaccines stimulate B cells to produce antibodies against the pathogen, while T cells are activated to destroy infected cells. This dual response helps to establish immunological memory, which enables a faster and more robust response upon re-exposure to the pathogen.

Pharmacokinetics

Vaccines are administered via various routes, including intramuscular, subcutaneous, and oral. After administration, the antigens are presented to antigen-presenting cells, which activate T cells and stimulate B cell proliferation and differentiation. The half-life of vaccine-induced immunity varies depending on the type of vaccine, with some providing lifelong immunity and others requiring booster doses to maintain protection.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Severe immunocompromised state for live attenuated vaccines

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Nausea

Interactions

• Immunosuppressive medications may reduce vaccine efficacy
• Concurrent administration of some vaccines may require spacing to optimize immune response

Precautions

• History of allergic reactions to vaccines or vaccine components
• Pregnancy (specific vaccines may be contraindicated)
• Moderate to severe acute illness with or without fever

Pregnancy

Consult healthcare provider. Some vaccines are contraindicated during pregnancy, while others are recommended.

Breast-feeding

Generally considered safe, but consult healthcare provider regarding specific vaccines.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Liquid suspension for injection
• Lyophilized powder for reconstitution